Press release
Leading Companies Fueling Growth and Innovation in the Semaglutides Market
Semaglutides Market
Projected Growth Trajectory of the Semaglutides Market by 2030
The semaglutides market is set to experience rapid growth, reaching a valuation of $45.42 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 12.0%. Several factors contribute to this surge, including broadened indications for obesity treatment, heightened demand for potent weight loss medications, and increased awareness about the cardiometabolic advantages of semaglutides. Additionally, advancements in next-generation GLP-1 therapies, a stronger healthcare emphasis on preventive metabolic care, and an evolving pipeline of innovative drugs are driving this growth. Key trends anticipated in the coming years include wider adoption of GLP-1 receptor agonists, growing use of semaglutide for obesity beyond diabetes treatment, preference for once-weekly injectable options, emerging acceptance of oral formulations, and rising demand for long-term management of metabolic diseases.
Download a free sample of the semaglutides market report:
https://www.thebusinessresearchcompany.com/report/semaglutides-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Steering the Semaglutides Market Forward
Several prominent firms currently dominate the semaglutides market. Among them are Novo Nordisk A/S, Eli Lilly and Company, Biocon Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Hanmi Pharmaceutical Co. Ltd., Samsung Bioepis, Celltrion Healthcare Co. Ltd., Alvotech, Sandoz Group AG, Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, and Adocia SA.
In a notable development in May 2024, Novo Holdings, a Denmark-based life sciences investment firm, acquired Catalent for $16.5 billion. This strategic move enhances Novo Holdings' portfolio by integrating Catalent's drug delivery expertise, biologics capabilities, and gene therapy technologies, thereby bolstering its position in the global healthcare arena. Catalent, headquartered in the United States, is a key manufacturer of semaglutide products.
Emerging Trends Shaping the Semaglutides Industry
Pharmaceutical companies in the semaglutides space are heavily invested in creating innovative, patient-friendly formulations aimed at improving weight control, blood sugar management, and cardiovascular health. These next-generation, long-acting drugs are designed to reduce dosing frequency and enhance patient convenience.
For example, in July 2025, Novo Nordisk A/S launched Wegovy, a semaglutide-based anti-obesity medication, in India targeting chronic weight management. Clinical trials have demonstrated its significant efficacy in weight loss. To make this treatment more accessible amid India's rising obesity rates, Novo Nordisk also reduced the price of Wegovy by 37%, enhancing affordability for a broader population.
View the full semaglutides market report:
https://www.thebusinessresearchcompany.com/report/semaglutides-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
In-Depth Segmentation of the Semaglutides Market
This report categorizes the semaglutides market across several critical segments:
1) By Brand - including Ozempic, Wegovy, and Rybelsus
2) By Route of Administration - oral and injectable forms
3) By Application - primarily Type 2 diabetes and obesity management
4) By End-User - hospitals and pharmacies, retail pharmacies, and online pharmacies
These classifications provide a comprehensive view of the market's structure and highlight key areas of focus for manufacturers and healthcare providers alike.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Companies Fueling Growth and Innovation in the Semaglutides Market here
News-ID: 4474063 • Views: …
More Releases from The Business Research Company
Leading Companies Fueling Growth and Innovation in the Teleprotection Market
The teleprotection market is on the brink of significant expansion as technological advancements and increasing industry demands drive its growth. This sector is expected to evolve rapidly in the coming years, fueled by developments in communication technology and the rising need for reliable protection systems across various applications. Let's explore the market's size projections, key players, emerging trends, and segmentation to understand its future trajectory.
Teleprotection Market Size Forecast Through 2030
The…
Competitive Landscape: Leading Companies and New Entrants in the Telecom Network …
The telecom network infrastructure sector is on the brink of substantial expansion, driven by rapid technological advancements and increasing demand for enhanced connectivity. As industries and consumers alike seek faster, more reliable communication networks, this market is set to experience significant growth over the coming years. Let's explore the market's projected valuation, leading companies, emerging trends, and key segments shaping its future.
Future Market Valuation and Growth Prospects for the Telecom…
Top Players and Market Competition in the Telecom Infrastructure Equipment Secto …
The telecom infrastructure equipment market is positioned for significant expansion as global demand for advanced communication technologies continues to rise. Driven by innovations and the rollout of next-generation networks, this sector is expected to experience steady growth that will reshape the landscape of telecommunications over the coming years. Let's explore the market size projections, key industry players, emerging trends, and detailed segment insights shaping this dynamic market.
Projected Growth and Market…
Market Trend Overview: The Impact of Recent Advancements on the Storage and Serv …
The storage and servers support services sector is set for consistent expansion over the coming years, driven by key technological advancements and evolving business needs. This market is responding to the growing importance of cloud computing, data security, and innovative storage solutions, promising steady growth through 2030.
Steady Market Growth Outlook for Storage and Servers Support Services
The market size for storage and servers support services is projected to reach $87.41 billion…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
